← All trials
NCT04954092
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 5, 2021
- Primary completion
- Nov 6, 2022
- Completion date
- Dec 31, 2023
- First posted
- Jul 8, 2021
- Last posted
- Sep 16, 2021
- Enrollment
- 3000
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of RussiaLead sponsor
- Government of RussiaOverall official - principal investigator
- Moscow City Health DepartmentOverall official - principal investigator
- Moscow Healthcare DepartmentCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.